Abstract:In order to obtain nanoparticles loaded with both the anticancer drug doxorubicin (DOX) and p53 gene, a pH-responsive doxorubicin prodrug and polycationic carrier can be respectively prepared through a combination of ring-opening polymerization (ROP) and “click” reaction. First, poly(ethylene glycol)monomethyl ether (mPEG) is used to initiate the ring-opening polymerization of a cyclic phosphoester monomer, 2-(but-3-yn-1-yloxy)-2-oxo-1,3,2-dioxaphospholane (abbreviated as BYP), resulting in a block copolymer precursor (mPEG-b-PBYP) containing alkynyl groups in the side chain. In another reaction, a pH-responsive doxorubicin derivative (DOX-hyd-N3) containing an azide group and an acid-sensitive hydrazone bond (-hyd-) is synthesized. Subsequently, the polymeric prodrug mPEG-b-PBYP-hyd-DOX is prepared by Cu(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” reaction between the alkynyl group of mPEG-b-PBYP and the azide group of DOX-hyd-N3. And the polycationic carrier (abbreviated as mPEG-b-PBYP-g-DAE) is obtained via the thiol-yne “click” reaction between mPEG-b-PBYP and 2-dimethylaminoethanethiol hydrochloride (DAE). The structures of mPEG-b-PBYP-hyd-DOX and mPEG-b-PBYP-g-DAE are characterized by magnetic resonance spectroscopy (NMR), gel permeation chromatography (GPC), ultraviolet-visible spectrophotometer (UV-vis), Fourier transform infrared spectroscopy (FT-IR), and high-performance liquid chromatography (HPLC) analyses. The two kinds of polymers can self-assemble into mixed micelles in aqueous solution, which are then combined with p53 gene by electrostatic interaction to form nanoparticles coencapsulated with the DOX and p53 gene. The size and morphology of the mixed micelles are characterized by dynamic light scattering (DLS) and transmission electron microscopy (TEM). And the release of DOX from the nanoparticles is studied by fluorescence spectrophotometer. The gene condensation ability of the mixed micelles is tested by zeta potential and gel retardation assay. Furthermore, in vitro cell experiments have proved the biocompatibility of the polymer precursor, the effect of nanoparticles on cancer cell inhibition, and the process of effective release of DOX and p53 gene after the nanoparticle enters the A549 cells by endocytosis. Meanwhile, the gene transfection effect of nanoparticles at different N/P ratios can be observed by confocal laser-scanning microscope. These results demonstrate that the DOX/p53 gene-coloaded nanoparticles have broad application prospects in the treatment of lung cancer.

Co-Delivery of Genes and Drugs with Nanostructured Calcium Carbonate for Cancer Therapy

Alginate/Caco3 Hybrid Nanoparticles For Efficient Codelivery Of Antitumor Gene And Drug

Alginate modified nanostructured calcium carbonate with enhanced delivery efficiency for gene and drug delivery.

Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail

Modification of calcium carbonate based gene and drug delivery systems by a cell-penetrating peptide.

Modification of nanostructured calcium carbonate for efficient gene delivery.

Inhibition of Multidrug Resistance of Cancer Cells by Co‐Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes

Advances of doxorubicin and gene in nano-drug delivery systems for codelivery

Multi‐functional heparin–biotin/heparin/calcium carbonate/calcium phosphate nanoparticles for targeted co‐delivery of gene and drug

Self-assembled Ph-Responsive DNA Nanosponges for Targeted Co-Delivery of Doxorubicin and Capsaicin for Colorectal Cancer Therapy

Intracellular Co-delivery of proteins and chemotherapeutics using calcium carbonate mineralized nanoparticles for osteosarcoma therapy

Tetrahedral DNA–mediated biomineralization of calcium carbonate nanoparticles for pH-responsive drug delivery

Lipid-Coated CaCO3 Nanoparticles As a Versatile Ph-Responsive Drug Delivery Platform to Enable Combined Chemotherapy of Breast Cancer

Stimuli-responsive Nanoparticles for the Codelivery of Chemotherapeutic Agents Doxorubicin and Sipd-L1 to Enhance the Antitumor Effect.

Construction of a High-Efficiency Drug and Gene Co-Delivery System for Cancer Therapy from a pH-Sensitive Supramolecular Inclusion between Oligoethylenimine- graft-β-cyclodextrin and Hyperbranched Polyglycerol Derivative

The Promising Nanocarrier for Doxorubicin and Sirna Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles.

Co-Delivery of Doxorubicin and Sirna with Reduction and Ph Dually Sensitive Nanocarrier for Synergistic Cancer Therapy

The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles.

CaCO<sub>3</sub> nanoplatform for cancer treatment: drug delivery and combination therapy

A Codelivery System of Anticancer Drug Doxorubicin and Tumor-Suppressor Gene P53 Based on Polyphosphoester for Lung Cancer Therapy

Co-Delivery of Doxorubicin and Survivin Shrna-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.